Tirzepatide, Liraglutide, and Semaglutide are the only three GLP-1 weight-control drugs currently approved by the FDA. According to JP Morgan Research, obesity and diabetes will drive the GLP-1 ...

AstraZeneca PLC (NASDAQ:AZN) is advancing in the weight loss and obesity treatment market with innovative drug candidates. AZD5004, an oral GLP-1 receptor agonist licensed from Eccogene, offers a ...

We recently published a list of 10 Best Weight Loss Drug Stocks to Buy According to Analysts. In this article, we are going to take a look at where GSK plc (NYSE ... GLP-1 weight-control drugs ...

We recently published a list of 10 Best Weight Loss Drug Stocks to Buy According to Analysts. In this article, we are going to take a look at where AstraZeneca PLC (NASDAQ:AZN) stands against other ...

We recently published a list of 10 Best Weight Loss Drug Stocks to Buy According to Analysts.In this article, we are going to take a look at where AstraZeneca PLC (NASDAQ:AZN) stands against other ...

We recently published a list of 10 Best Weight Loss Drug Stocks to Buy According to Analysts. In this article, we are going to take a look at where GSK plc (NYSE:GSK) stands against other best weight ...